|
=
Dr. Iok-Hou Pang
Associate Director
|
Recent
Progress in Glaucoma Research
Dr.
Iok-Hou Pang e=
arned
his B.S. in Pharmacy at the National
Defense Medical
Center in Taipei,
Taiwan and a Ph.D. in
Pharmacology at the University of Texas Southwestern Medical Center, Dallas, Texas.
He has been involved in drug discovery for glaucoma at Alcon Laboratories=
, Fort Worth=
, Texas, since 1990.&=
nbsp;
He is currently an associate director in Glaucoma Research. Dr. Pa=
ng
is also an adjunct associate professor and graduate student advisor in
University of North Texas Health Science Center at Fort Worth,
a visiting professor in National Defense Medical
Center in Taipei,
and a visiting scientist in the Shanxi
Eye Hospital
in Taiyuan.
Dr. Pang’s current research interests
mainly focus on the understanding of glaucoma etiology and the developmen=
t of
new drugs for its treatment. Dr. Pang has been issued 9 Patents and co-authored more than 60
manuscripts and book chapters.
Abstract:
Glaucoma is one of the leading causes of blindness on earth. One of the r=
isk
factors in glaucoma is an abnormal increase in the pressure inside the ey=
e.
This excessive pressure kills a specific cell type, the ganglion cells, in
the retina, which eventually leads to loss of vision.
This presentation w=
ill
describe pathological mechanisms involved in this disease, provide a conc=
ise
review of major drugs and surgical procedures currently used for its
treatment and introduce new technological breakthroughs in glaucoma resea=
rch.
The presentation will conclude with a brief discussion on potential
challenges in future research.
|
![](3D"Pang_iokhou_files/image004.jpg")